BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7763119)

  • 1. Toward improved glycemic control in diabetes. What's on the horizon?
    Gray H; O'Rahilly S
    Arch Intern Med; 1995 Jun; 155(11):1137-42. PubMed ID: 7763119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L; Hirsch IB
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Objectives and therapeutic strategy in type 2 diabetes mellitus].
    Calvo Romero JM; Lima Rodríguez EM
    An Med Interna; 2001 Jul; 18(7):381-8. PubMed ID: 11534426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    Viberti G
    J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection in diabetes: role of glycemic control.
    Fioretto P; Bruseghin M; Berto I; Gallina P; Manzato E; Mussap M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S86-9. PubMed ID: 16565255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise and glycemic control in diabetes: benefits, challenges, and adjustments to pharmacotherapy.
    Gulve EA
    Phys Ther; 2008 Nov; 88(11):1297-321. PubMed ID: 18801852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus.
    Rosa JS; Flores RL; Oliver SR; Pontello AM; Zaldivar FP; Galassetti PR
    Pediatr Diabetes; 2008 Feb; 9(1):9-16. PubMed ID: 18211631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypoglycemic treatment of type 2 diabetes].
    Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for type 2 diabetes mellitus.
    Elson DF; Meredith M
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diabetes Control and Complications Trial Study: implications for the diabetic foot.
    DeFronzo RA; Reasner C
    J Foot Ankle Surg; 1994; 33(6):551-6. PubMed ID: 7894400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidiabetic therapy in diabetic patients with coronary heart disease].
    Faglia E
    Minerva Med; 2003 Dec; 94(6):387-99. PubMed ID: 14976467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ; Forrest KY; Ellis D; Becker DJ
    Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for managing diabetic patients on peritoneal dialysis.
    Dasgupta MK
    Adv Perit Dial; 2004; 20():200-2. PubMed ID: 15384826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly approved and promising antidiabetic agents.
    Combettes M; Kargar C
    Therapie; 2007; 62(4):293-310. PubMed ID: 17983555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.
    Lebovitz HE
    J Indian Med Assoc; 2008 Nov; 106(11):724-6. PubMed ID: 19368098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.